Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 5.7% in the last trading session to close at $22.36. The move was backed by solid volume with far more shares changing hands than in a normal ...

Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 5.8% in the last trading session to close at $21.17. The move was backed by solid volume with far more shares changing hands than in a normal ...

Silence Therapeutics PLC ADR Annual stock financials by MarketWatch. View the latest SLN financial statements, income statements and financial ratios.

Goldman Sachs initiated Silence Therapeutics (NASDAQ:SLN) with a Sell rating and a $6 price target on Tuesday, arguing that with only about $173M of cash and equivalents at the end of Q3 2024, the U.K ...

A newly released economic impact study by the Docking Institute of Public Affairs at Fort Hays State University confirms the ...